Needham & Company Reiterates a 'Buy' on Solta Medical (SLTM); Good Quarter

May 2, 2012 9:20 AM EDT Send to a Friend
Get Alerts SLTM Hot Sheet
Price: $2.14 +0.47%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 15 | New: 13
Trade SLTM Now!
Needham & Company reiterates a 'Buy' on Solta Medical (NASDAQ: SLTM) price target of $4.00.

Analyst, Dal ton Chandler, said, "The LipoSonix body contouring device was launched in January about three months after it was acquired from Medicis (NYSE: MRX)(notrated) and it appears to be off to a very strong start. Contradicting a competitor’s earlier comments, management maintained that the ASP on the 78 new devices placed in the quarter was greater than $90 K and at better margins than the core equipment. The company also sold 11 upgrade units." (Needham lowers FY12 EPS from (0.04) to (0.17)

For an analyst ratings summary and ratings history on Solta Medical click here. For more ratings news on Solta Medical click here.

Shares of Solta Medical closed at $3.24 yesterday, with a 52 week range of $1.15-$3.69.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Needham & Company

Add Your Comment